CoChat

3-O-Methylfunicone, a Selective Inhibitor of Mammalian Y-Family DNA Polymerases from an Australian Sea Salt Fungal Strain

Open access

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

We isolated a pol inhibitor from the cultured mycelia extract of a fungal strain isolated from natural salt from a sea salt pan in Australia, which was identified as 3-O-methylfunicone by spectroscopic analyses. This compound selectively inhibited the activities of mammalian Y-family DNA polymerases (pols) (i.e., pols η, ι and κ). Among these pols, human pol κ activity was most strongly inhibited, with an IC50 value of 12.5 μM. On the other hand, the compound barely influenced the activities of the other families of mammalian pols, such as A-family (i.e., pol γ), B-family (i.e., pols α, δ and ε) or X-family (i.e., pols β, λ and terminal deoxynucleotidyl transferase), and showed no effect on the activities of fish pol δ, plant pols, prokaryotic pols and other DNA metabolic enzymes, such as calf primase of pol α, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase or bovine deoxyribonuclease I. This compound also suppressed the growth of two cultured human cancer cell lines, HCT116 (colon carcinoma cells) and HeLa (cervix carcinoma cells), and UV-treated HeLa cells exhibited lower clonogenic survival in the presence of inhibitor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md7040624

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Structure of compound 1 (3-O-methylfunicone).
Figure 1. Structure of compound 1 (3-O-methylfunicone).CC BY · PubMed Central
Figure 2. Effect of 3-O-methylfunicone (1) on the activities of various DNA polymerases and other DNA metabolic enzymes. (A) Mammalian pols, (B) fish, insect, plant and prokaryotic pols, and (C) other DNA metabolic enzymes. Compound 1 (100 μM) was incubated with each enzyme (0.05 units). % of relative activity. Enzymatic activities were measured as described in the Experimental section. Activities in the absence of the compounds were taken as 100%. Data are shown as the means ± SEM of four independent experiments.
Figure 2. Effect of 3-O-methylfunicone (1) on the activities of various DNA polymerases and other DNA metabolic enzymes. (A) Mammalian pols, (B) fish, insect, plant and prokaryotic pols, and (C) other DNA metabolic enzymes. Compound 1 (100 μM) was incubated with each enzyme (0.05 units). % of relative activity. Enzymatic activities were measured as described in the Experimental section. Activities in the absence of the compounds were taken as 100%. Data are shown as the means ± SEM of four independent experiments.CC BY · PubMed Central
Figure 3. Mammalian Y-family DNA polymerase inhibition dose-response curves of 3-O-methylfunicone (1). Compound 1 was incubated with human pol η (square), mouse pol ι (triangle), and human pol κ (circle) (0.05 units of each). Pol activity was measured as described in the Experimental section. Activity in the absence of the compounds was taken as 100%. Data are shown as the means ± SEM of three independent experiments.
Figure 3. Mammalian Y-family DNA polymerase inhibition dose-response curves of 3-O-methylfunicone (1). Compound 1 was incubated with human pol η (square), mouse pol ι (triangle), and human pol κ (circle) (0.05 units of each). Pol activity was measured as described in the Experimental section. Activity in the absence of the compounds was taken as 100%. Data are shown as the means ± SEM of three independent experiments.CC BY · PubMed Central
Figure 4. Kinetic analysis of the inhibition of human pol κ by compound 1. (A) Human pol κ activity was measured in the absence (closed square) or presence of 4 μM (closed circle), 8 μM (closed triangle) or 12 μM (closed diamond) compound 1 using the indicated concentrations of the DNA template-primer. (B) Human pol κ activity was assayed with the indicated concentrations of the substrate dTTP in the presence of 4 μM (open circle), 8 μM (open triangle) or 12 μM (open diamond) or in the absence (open square) of compound 1. (C) and (D) The inhibition constants (Ki) were determined as 1.3 and 4.4 μM from a Dixon plot made on the basis of the same data for (A) and (B), respectively. Amount of human pol κ in the assay mixture was 0.05 units.
Figure 4. Kinetic analysis of the inhibition of human pol κ by compound 1. (A) Human pol κ activity was measured in the absence (closed square) or presence of 4 μM (closed circle), 8 μM (closed triangle) or 12 μM (closed diamond) compound 1 using the indicated concentrations of the DNA template-primer. (B) Human pol κ activity was assayed with the indicated concentrations of the substrate dTTP in the presence of 4 μM (open circle), 8 μM (open triangle) or 12 μM (open diamond) or in the absence (open square) of compound 1. (C) and (D) The inhibition constants (Ki) were determined as 1.3 and 4.4 μM from a Dixon plot made on the basis of the same data for (A) and (B), respectively. Amount of human pol κ in the assay mixture was 0.05 units.CC BY · PubMed Central
Figure 5. (A) Human cancer cell growth inhibition dose-response curves of 3-O-methyl-funicone (1). Various concentrations (0 to 150 μM) of compound 1 were incubated with human colon carcinoma (HCT116) cells (circle) and human cervix carcinoma (HeLa) cells (square) for 24 h. Rate of cell growth was determined by MTT assay [44] as described in the Experimental section. Data are shown as the means ± SEM of five independent experiments. (B) Clonogenic survival of UV-treated HeLa cells by compound 1. Various concentrations (0 to 100 μM) of compound 1 were incubated with 10 J/m2 UV-treated (closed circle) or untreated (open circle) HeLa cells. After 7 days, the number of colonies in each treatment group was counted. Values are the means ± SEM of two independent experiments.
Figure 5. (A) Human cancer cell growth inhibition dose-response curves of 3-O-methyl-funicone (1). Various concentrations (0 to 150 μM) of compound 1 were incubated with human colon carcinoma (HCT116) cells (circle) and human cervix carcinoma (HeLa) cells (square) for 24 h. Rate of cell growth was determined by MTT assay [44] as described in the Experimental section. Data are shown as the means ± SEM of five independent experiments. (B) Clonogenic survival of UV-treated HeLa cells by compound 1. Various concentrations (0 to 100 μM) of compound 1 were incubated with 10 J/m2 UV-treated (closed circle) or untreated (open circle) HeLa cells. After 7 days, the number of colonies in each treatment group was counted. Values are the means ± SEM of two independent experiments.CC BY · PubMed Central
Figure 6. (Left) Isolation methods of marine fungal strains from Australian sea salt. (Right) Purification procedure of a compound with pol inhibitory activity from mycelia of “AF1-2” fungal strain.
Figure 6. (Left) Isolation methods of marine fungal strains from Australian sea salt. (Right) Purification procedure of a compound with pol inhibitory activity from mycelia of “AF1-2” fungal strain.CC BY · PubMed Central
Figure 7. Assay method of pol inhibitor.
Figure 7. Assay method of pol inhibitor.CC BY · PubMed Central
Figure 8. Marine fungal strain AF1-2.
Figure 8. Marine fungal strain AF1-2.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 44

Metadata

Authors
Mizushina, Y., Motoshima, H., Yamaguchi, Y., Takeuchi, T., Hirano, K., Sugawara, F., & Yoshida, H.
Affiliations
  • Kobe Gakuin University (JP)
  • Tokyo University of Science (JP)
  • Nano-bioanalysis Team, Health Technology Research Center, Takamatsu, Kagawa 761-0395 Japan
Corresponding author
Mizushina, Yoshiyuki
Venue
Marine Drugs
Publisher
MDPI AG
Published
2009-11-23
Volume
7
Issue
4
Pages
624-639
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2119902836
Cited by
42
References
46
Citations by year
2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2013: 5 · 2012: 5
FWCI
3.37
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Salt Science Research Foundation
  • Ministry of Education, Culture, Sports, Science and Technology (19680031, 2006–2010)
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
Keywords
Y-family DNA polymerases, DNA polymerase kappa, DNA polymerase eta, DNA polymerase iota, marine fungi, anticancer activity, UV-induced DNA damage, clonogenic survival, HCT116 cells, HeLa cells
MeSH terms
Animals, Antineoplastic Agents, Australia, Cattle, DNA Nucleotidylexotransferase, DNA-Directed DNA Polymerase, Drug Screening Assays, Antitumor, Fungi, Humans, IMP Dehydrogenase, Nucleotidyltransferases, Pyrones, Salts, Seawater, Structure-Activity Relationship, Nucleic Acid Synthesis Inhibitors, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 3-O-Methylfunicone, a Selective Inhibitor of Mammalian Y-Family DNA Polymerases from an Australian Sea Salt Fungal Strain. https://app.cochat.ai/papers/10.3390/md7040624
The paper
Mizushina, Y., Motoshima, H., Yamaguchi, Y., Takeuchi, T., Hirano, K., Sugawara, F., & Yoshida, H. (2009). 3-O-Methylfunicone, a Selective Inhibitor of Mammalian Y-Family DNA Polymerases from an Australian Sea Salt Fungal Strain. Marine Drugs. https://doi.org/10.3390/md7040624

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.